Sex differences in antinociceptive and motoric effects of cannabinoids.

[1]  M. Greenwald,et al.  Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. , 2000, Drug and alcohol dependence.

[2]  J. Walker,et al.  Activational role of cannabinoids on movement. , 2000, European journal of pharmacology.

[3]  J. Manzanares,et al.  Cannabinoids as potential new analgesics. , 1999, Life sciences.

[4]  R. Craft,et al.  Sex differences in development of morphine tolerance and dependence in the rat , 1999, Psychopharmacology.

[5]  J. Vivian,et al.  Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A. , 1998, The Journal of pharmacology and experimental therapeutics.

[6]  J. Lowe,et al.  Characterization of Δ9-Tetrahydrocannabinol and Anandamide Antinociception in Nonarthritic and Arthritic Rats , 1998, Pharmacology Biochemistry and Behavior.

[7]  H. Taylor.  Analysis of the medical use of marijuana and its societal implications. , 1998, Journal of the American Pharmaceutical Association.

[8]  K. Jen,et al.  Differential Gender Response Produced by Meal and Ad Lib Feedings of a High-Fat Diet in Osborne-Mendel Rats , 1997, Physiology & Behavior.

[9]  G. Bennett,et al.  The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain , 1997, Neuroscience Letters.

[10]  S. Welch,et al.  Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine. , 1995, The Journal of pharmacology and experimental therapeutics.

[11]  S. L. Patrick,et al.  Antinociceptive actions of cannabinoids following intraventricular administration in rats , 1993, Brain Research.

[12]  S. Welch,et al.  Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. , 1992, The Journal of pharmacology and experimental therapeutics.

[13]  I. Yamamoto,et al.  Sex difference in the oxidative metabolism of Δ9-tetrahydrocannabinol in the rat , 1991 .

[14]  B. Thomas,et al.  Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency. , 1990, The Journal of pharmacology and experimental therapeutics.

[15]  B. Thomas,et al.  In vitro metabolism of (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl) phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol, a synthetic bicyclic cannabinoid analog. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[16]  J. D. Neill,et al.  The Physiology of reproduction , 1988 .

[17]  B. Martin.  Structural requirements for cannabinoid-induced antinociceptive activity in mice. , 1985, Life sciences.

[18]  R. Tallarida,et al.  Manual of Pharmacologic Calculations: With Computer Programs , 1984 .

[19]  B. Tocqué,et al.  The Kinetics of Cannabinoid Distribution and Storage With Special Reference to the Brain and Testis , 1981, Journal of clinical pharmacology.

[20]  R. Tallarida,et al.  Manual of Pharmacologic Calculations , 1981 .

[21]  I. Yamamoto,et al.  Comparison in mice of pharmacological effects of delta 8-tetrahydrocannabinol and its metabolites oxidized at 11-position. , 1980, European journal of pharmacology.

[22]  L. H. Miller,et al.  Drug addiction : experimental pharmacology , 1972 .